MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 48 filers reported holding MEI PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $50,000 | -82.5% | 82,902 | -22.6% | 0.00% | -100.0% |
Q4 2021 | $286,000 | -63.6% | 107,052 | -62.4% | 0.00% | -50.0% |
Q3 2021 | $786,000 | -10.5% | 284,847 | -7.6% | 0.00% | -20.0% |
Q2 2021 | $878,000 | +29.7% | 308,183 | +56.1% | 0.01% | +25.0% |
Q1 2021 | $677,000 | -50.8% | 197,484 | -62.1% | 0.00% | -50.0% |
Q4 2020 | $1,376,000 | -17.2% | 521,135 | -2.1% | 0.01% | -20.0% |
Q3 2020 | $1,662,000 | -18.4% | 532,553 | +7.9% | 0.01% | -23.1% |
Q2 2020 | $2,038,000 | +763.6% | 493,554 | +236.3% | 0.01% | +550.0% |
Q1 2020 | $236,000 | -26.9% | 146,779 | +12.7% | 0.00% | +100.0% |
Q4 2019 | $323,000 | +348.6% | 130,208 | +681.1% | 0.00% | – |
Q3 2018 | $72,000 | +4.3% | 16,670 | -4.6% | 0.00% | – |
Q2 2018 | $69,000 | -26.6% | 17,468 | -61.5% | 0.00% | – |
Q1 2018 | $94,000 | -1.1% | 45,385 | 0.0% | 0.00% | – |
Q4 2017 | $95,000 | -24.0% | 45,385 | -2.5% | 0.00% | – |
Q3 2017 | $125,000 | +861.5% | 46,566 | +755.5% | 0.00% | – |
Q2 2017 | $13,000 | +44.4% | 5,443 | 0.0% | 0.00% | – |
Q1 2017 | $9,000 | -91.2% | 5,443 | -91.4% | 0.00% | -100.0% |
Q4 2015 | $102,000 | -86.2% | 63,549 | -86.5% | 0.00% | -75.0% |
Q3 2015 | $741,000 | +4.5% | 471,702 | +13.8% | 0.00% | 0.0% |
Q2 2015 | $709,000 | -39.0% | 414,589 | -36.2% | 0.00% | -33.3% |
Q1 2015 | $1,163,000 | – | 649,580 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|